

When dealing with potential sites, sponsors should clearly convey that eConsent is the established and expected method for consenting patients, honing into the information to demonstrate how it will benefit them and their patients.
Traditionally, the creation of the electronic informed consent form (eICF) would not take place until approval of the paper ICF per country/site was received.
Optimizing the submission strategy would be a KEY -- in partnership with IRBs and ethics committees by approaching the ICF digitization in parallel with the paper ICF approval process. This approach enables the sponsor to be ready to start consenting patients by the site initiation visit (SIV), a critical rung in the ladder to higher eConsent site adoption.
When sites are trained and confident to start consenting electronically from the first patient visit, we see them the technology rapidly—bringing on multiple benefits.